These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22872229)

  • 1. Effectiveness of the Austrian disease management programme "Therapie Aktiv" for type 2 diabetes regarding the improvement of metabolic control, risk profile and guideline adherence: 2 years of follow up.
    Flamm M; Panisch S; Winkler H; Johansson T; Weitgasser R; Sönnichsen AC
    Wien Klin Wochenschr; 2012 Sep; 124(17-18):639-46. PubMed ID: 22872229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of the Austrian disease management programme for type 2 diabetes: a cluster-randomised controlled trial.
    Sönnichsen AC; Winkler H; Flamm M; Panisch S; Kowatsch P; Klima G; Fürthauer B; Weitgasser R
    BMC Fam Pract; 2010 Nov; 11():86. PubMed ID: 21054881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing with Learning Disability and Diabetes: OK-Diabetes - a case-finding study and feasibility randomised controlled trial.
    House A; Bryant L; Russell AM; Wright-Hughes A; Graham L; Walwyn R; Wright JM; Hulme C; O'Dwyer JL; Latchford G; Meer S; Birtwistle JC; Stansfield A; Ajjan R; Farrin A
    Health Technol Assess; 2018 May; 22(26):1-328. PubMed ID: 29845932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Evaluation of the Effectiveness of Austrians Disease Management Program in Patients with Type 2 Diabetes Mellitus - A Population-Based Retrospective Cohort Study.
    Riedl R; Robausch M; Berghold A
    PLoS One; 2016; 11(8):e0161429. PubMed ID: 27532885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of diabetes care in Austrian diabetic patients willing to participate in a DMP - at baseline.
    Flamm M; Winkler H; Panisch S; Kowatsch P; Klima G; Fürthauer B; Weitgasser R; Sönnichsen AC
    Wien Klin Wochenschr; 2011 Jul; 123(13-14):436-43. PubMed ID: 21691756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of a Peer Support Programme versus Usual Care in Disease Management of Diabetes Mellitus Type 2 regarding Improvement of Metabolic Control: A Cluster-Randomised Controlled Trial.
    Johansson T; Keller S; Winkler H; Ostermann T; Weitgasser R; Sönnichsen AC
    J Diabetes Res; 2016; 2016():3248547. PubMed ID: 26858958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection effects may account for better outcomes of the German Disease Management Program for type 2 diabetes.
    Schäfer I; Küver C; Gedrose B; von Leitner EC; Treszl A; Wegscheider K; van den Bussche H; Kaduszkiewicz H
    BMC Health Serv Res; 2010 Dec; 10():351. PubMed ID: 21194442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of the Disease Management Program on HbA1c Value in Type 2 Diabetes Mellitus Patients: A Retrospective Comparison between Disease Management Programs and Standard Care].
    Wiefarn S; Kostev K; Heumann C; Rettelbach A
    Dtsch Med Wochenschr; 2017 Oct; 142(21):e148-e155. PubMed ID: 28915520
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of a randomized control group on perceived effectiveness of a Disease Management Programme for diabetes type 2.
    Flamm M; Panisch S; Winkler H; Sönnichsen AC
    Eur J Public Health; 2012 Oct; 22(5):625-9. PubMed ID: 21990343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIal to slow the Progression Of Diabetes (TRIPOD): study protocol for a randomized controlled trial using wireless technology and incentives.
    Lim RSM; Gardner DSL; Bee YM; Cheung YB; Bairavi J; Gandhi M; Goh SY; Ho ETL; Lin X; Tan NC; Tay TL; Finkelstein EA
    Trials; 2019 Nov; 20(1):650. PubMed ID: 31779678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health Coaching Reduces HbA1c in Type 2 Diabetic Patients From a Lower-Socioeconomic Status Community: A Randomized Controlled Trial.
    Wayne N; Perez DF; Kaplan DM; Ritvo P
    J Med Internet Res; 2015 Oct; 17(10):e224. PubMed ID: 26441467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency of the Austrian disease management program for diabetes mellitus type 2: a historic cohort study based on health insurance provider's routine data.
    Ostermann H; Hoess V; Mueller M
    BMC Public Health; 2012 Jun; 12():490. PubMed ID: 22742209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease Management Program in patients with type 2 diabetes mellitus, long-term results of the early and established program cohort: A population-based retrospective cohort study.
    Riedl R; Robausch M; Berghold A
    PLoS One; 2022; 17(12):e0279090. PubMed ID: 36512601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results from the CLUES study: a cluster randomized trial for the evaluation of cardiovascular guideline implementation in primary care in Spain.
    Etxeberria A; Alcorta I; Pérez I; Emparanza JI; Ruiz de Velasco E; Iglesias MT; Rotaeche R
    BMC Health Serv Res; 2018 Feb; 18(1):93. PubMed ID: 29422049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BetaMe: impact of a comprehensive digital health programme on HbA1c and weight at 12 months for people with diabetes and pre-diabetes: study protocol for a randomised controlled trial.
    Sarfati D; McLeod M; Stanley J; Signal V; Stairmand J; Krebs J; Dowell A; Leung W; Davies C; Grainger R
    Trials; 2018 Mar; 19(1):161. PubMed ID: 29506562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of a diabetes education and self management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: three year follow-up of a cluster randomised controlled trial in primary care.
    Khunti K; Gray LJ; Skinner T; Carey ME; Realf K; Dallosso H; Fisher H; Campbell M; Heller S; Davies MJ
    BMJ; 2012 Apr; 344():e2333. PubMed ID: 22539172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The GIANT study, a cluster-randomised controlled trial of efficacy of education of doctors about type 2 diabetes mellitus management guidelines in primary care practice.
    Reutens AT; Hutchinson R; Van Binh T; Cockram C; Deerochanawong C; Ho LT; Ji L; Khalid BA; Kong AP; Lim-Abrahan MA; Tan CE; Tjokroprawiro A; Yoon KH; Zimmet PZ; Shaw JE
    Diabetes Res Clin Pract; 2012 Oct; 98(1):38-45. PubMed ID: 22784926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a Collaborative Care Model on Depressive Symptoms and Glycated Hemoglobin, Blood Pressure, and Serum Cholesterol Among Patients With Depression and Diabetes in India: The INDEPENDENT Randomized Clinical Trial.
    Ali MK; Chwastiak L; Poongothai S; Emmert-Fees KMF; Patel SA; Anjana RM; Sagar R; Shankar R; Sridhar GR; Kosuri M; Sosale AR; Sosale B; Rao D; Tandon N; Narayan KMV; Mohan V;
    JAMA; 2020 Aug; 324(7):651-662. PubMed ID: 32809002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Disease Management Programs on HbA1c Values in Type 2 Diabetes Patients in Germany.
    Kostev K; Rockel T; Jacob L
    J Diabetes Sci Technol; 2017 Jan; 11(1):117-122. PubMed ID: 27246670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal study examining adherence to guidelines in diabetes care according to different definitions of adequacy and timeliness.
    Sidorenkov G; Haaijer-Ruskamp FM; de Zeeuw D; Denig P
    PLoS One; 2011; 6(9):e24278. PubMed ID: 21931669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.